JP Morgan Chase’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Sell |
|
|||||
|
2025
Q4 | $4.64M | Sell |
|
|||||
|
2025
Q3 | $4.59M | Sell |
|
|||||
|
2025
Q2 | $5.7M | Buy |
|
|||||
|
2025
Q1 | $1.44M | Sell |
|
|||||
|
2024
Q4 | $7.15M | Sell |
|
|||||
|
2024
Q3 | $14.5M | Buy |
|
|||||
|
2024
Q2 | $547K | Sell |
|
|||||
|
2024
Q1 | $1.94M | Buy |
|
|||||
|
2023
Q4 | $518K | Buy |
|
|||||
|
2023
Q3 | $393K | Buy |
|
|||||
|
2023
Q2 | $347K | Buy |
|
|||||
|
2023
Q1 | $188K | Buy |
|
|||||
|
2022
Q4 | $167K | Buy |
|
|||||
|
2022
Q3 | $172K | Buy |
|
|||||
|
2022
Q2 | $142K | Buy |
|
|||||
|
2022
Q1 | $67K | Sell |
|
|||||
|
2021
Q4 | $3.93M | Buy |
|
|||||
|
2021
Q3 | $70K | Sell |
|
|||||
|
2021
Q2 | $150K | Sell |
|
|||||
|
2021
Q1 | $352K | Sell |
|
|||||
|
2020
Q4 | $694K | Buy |
|